PTK7 expression analysis revealed varying antigen densities across five bladder cancer cell lines, ranging from approximately 10,000 to 70,000 sites per cell. The chimeric anti-PTK7 antibody demonstrated apparent equilibrium dissociation constants of 10–44 nM with moderate binding affinity suitable for therapeutic applications. The gene discussed is PTK7; the disease is urinary bladder carcinoma.